Peptide record

TPDB45773

Antiviral standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45773
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 14-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
HAVGNDTSNHGVTA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C55H86N20O22
RCEQILKMFPWY
ANGHTV
1379.41
6.01
2
1
4
-1
1.88
-0.564
55.71
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
0
0.00
5
Residue Composition
number
2
A
0
R
2
N
1
D
0
C
0
E
0
Q
2
G
2
H
0
I
0
L
0
K
0
M
0
F
0
P
1
S
2
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 2 D: 1 C: 0 E: 0 Q: 0 G: 2 H: 2 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 1 T: 2 W: 0 Y: 0 V: 2
Chemical Descriptors
14 reviewed residue count
C55H86N20O22 sequence-only estimate (linear, free termini)
1379.41 sequence-only estimate (linear, free termini)
6.01 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
1.88 sequence-only estimate (linear, free termini)
-0.564 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0